Printer Friendly Version

Send to a Friend

Bristol-Myers will construct a 750,000-sf large-scale biologics manufacturing faciltiy on 85 acres at the former Fort Devens Army Base in Devens, Mass. The $1.1-billion project includes a $660-million capital expenditure by Bristol-Myers to construct a plant for the the manufacturing of biologics compounds including the rheumatoid arthritis treatment Orencia. Construction will begin in September 2006 with completion slated for 2009 and production to begin in late 2011.